Relapsed or Refractory Multiple Myeloma (RRMM) (DBCOND0163508)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06615479	A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-refractory Multiple Myeloma (QUINTESSENTIAL-2)	Carfilzomib Cyclophosphamide Daratumumab Dexamethasone Fludarabine Pomalidomide	treatment	3	not_yet_recruiting
NCT06484829	Puesta Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma	No drug interventions	other	1 / 2	not_yet_recruiting
NCT04824794	GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies	Daratumumab Erzotabart Hyaluronidase (human recombinant)	treatment	1 / 2	recruiting